Synthetic multivalent ligands in the exploration of cell-surface interactions

Current Opinion in Chemical Biology

Volumn 4, Issue 6, 2000, Pages 696-703

  Kiessling, Laura L ^a   Gestwicki, Jason E ^a   Strong, Laura E ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Quintessense Biosciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; LIGAND;

BINDING SITE; CELL INTERACTION; CELL SURFACE; CHEMICAL STRUCTURE; LIGAND BINDING; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033638783     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(00)00153-8     Document Type: Review

References (63)

1. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors
2. Principles for multivalent ligand design
3. Effect of shape, size, and valency of multivalent mannosides on their binding properties to phytohemagglutinins
4. Carbohydrate-protein interactions: Basis of glycobiology
5. Strength in numbers: Non-natural polyvalent carbohydrate derivatives
6. A trivalent system from vancomycin·D-Ala-D-Ala with higher affinity than avidin·biotin
7. Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into the mechanism of inhibition
8. Synthetic polymeric sialoside inhibitors of influenza virus receptor-binding activity
9. Polyacrylamides bearing pendant α-sialoside groups strongly inhibit agglutination of erythrocytes by influenza virus
10. Inhibition of influenza A virus hemagglutinin and induction of interferon by synthetic sialylated glycoconjugates
11. Synthesis of cluster sialoside inhibitors for influenza virus
12. Molecular recognition of bivalent sialosides by influenza virus
13. A lysoganglioside/poly-L-glutamic acid conjugate as a picomolar inhibitor of influenza hemagglutinin
14. Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers
15. Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: A 500 MHz proton nuclear magnetic resonance study
16. The agglutination of erythrocytes by influenza virus is strongly inhibited by liposomes incorporating an analog of sialyl gangliosides
17. Polymerized liposomes containing C-glycosides of sialic acid: Potent inhibitors of influenza virus in vitro infectivity
18. Generation and in situ evaluation of libraries of poly(acrylic acid) presenting sialcsides as side chains as polyvalent inhibitors of influenza-mediated hemagglutination
19. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligans
20. High-affinity pentavalent ligands of Escherichia coli heat-labile enterotoxin by modular structure-based design
21. Lactose binding to heat-labile enterotoxin revealed by X-ray crystallography
22. 3
23. Enhanced inhibition of human anti-gal antibody binding to mammalian cells by synthetic α-gal epitope polymers
24. Nonstatistical binding of a protein to clustered carbohydrates
25. Cell adhesion and motility depends on nanoscale RGD clustering
26. Cluster mannosides as inhibitors of type 1 fimbriae-mediated adhesion of Escherichia coli: Pentaerythdtol derivatives as scaffolds
27. A surface chemistry approach to studying cell adhesion
28. Cell surface engineering by a modified Staudinger reaction
29. Micropatterned surfaces for control of cell shape, position, and function
30. Dimerization as a regulatory mechanism in signal transduction
31. Dimerization of cell surface receptors in signal transduction
32. The dynamics of T cell receptor signaling: Complex orchestration and the key roles of tempo and cooperation
33. Positive versus negative signaling by lymphocyte antigen receptors
34. Controlling signal transduction with synthetic ligands
35. Glycopeptide- and carbohydrate-based synthetic vaccines for the immunotherapy of cancer
36. Synthetic carbohydrate vaccines based on tumor-associated antigens
37. Glycosphingolipid antigens and cancer therapy
38. Cancer immunotherapy: Synthetic and natural peptides in the balance
39. From the laboratory to the clinic: A retrospective on fully synthetic carbohydrate-based anticancer vaccines
40. Design of peptide and polypeptide vaccines
41. Carbohydrate antigens as targets for active specific immunotherapy
42. Probing cell surface 'glyco-architecture' through total synthesis, immunological consequenses of a human blood group determinant in a clustered mucin-like context
43. Polyclonal antibodies from patients immunized with a globo H-keyhole limpet hemocyanin vaccine: Isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigens
44. Design and synthesis of Ley-bearing glycopeptides that mimic cell surface Le(Y) mucln glycoprotein architecture
45. Synthetic peptide vaccine design - Synthesis and properties of a high-density multiple antigenic peptide system
46. Preparation of a multiple antigen glycopeptide (MAG) carrying the Tn antigen
47. Peptide and glycopeptide dendrimers. Part 1
48. The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers
49. + T cells in peripheral blood and liver using peptide-MHC tetramers
50. Multivalent thioether-peptide conjugates: B cell tolerance of an anti-peptide immune response
51. Immunospecific reduction of antioligonucleotide antibody-forming cells with a tetrakis-oligonucleotide conjugate (LJP-394), a therapeutic candidate for the treatment of lupus nephritis
52. Receptor clustering as a cellular mechanism to control sensitivity
53. Receptor-mediated protein kinase activation and the mechanism of transmembrane signaling in bacterial chemotaxis
54. Tuning chemotactic responses with synthetic ligands
55. Synthesis of end-labeled multivalent ligands for exploring cell-surface-receptor-ligand interactions
56. Selectincarbohydrate interactions: From natural ligands to designed mimics
57. A facile synthetic approach to L- and P-selectin blockers via copolymerization of vinyl monomers constructing the key carbohydrate modules of sialyl lewis(X) mimics
58. Enzymatic synthesis of alpha 3'-sialylated and multiply alpha 3-fucosylated biantennary polylactosamines - A bivalent [sialyl diLe(x)]-saccharide inhibited lymphocyte-endothelium adhesion organ-selectively
59. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors
60. Glycoprotein-inspired materials promote the proteolytic release of cell surface L-selectin
61. Synthetic ligands effect cell surface strategies
62. Inhibition of L-selectin-mediated leukocyte rolling by synthetic glycoprotein mimics
63. A diverse set fo oligomeric class II MHC-peptide complexes for probing T-cell receptor interactions